Latest data from September 24, 2021
Number of Health Center respondents = 12 (75% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 5,376 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 88.28% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 301 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 92.52% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 10.10% | 6.31% |
| White, Hispanic/Latino Patients | 15.83% | 12.96% |
| Black/African American, Non-Hispanic/Latino Patients | 26.60% | 28.90% |
| Black/African American, Hispanic/Latino Patients | 2.42% | 2.99% |
| Asian Patients3 | 1.58% | 0.33% |
| American Indian/Alaska Native Patients3 | 0.26% | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.69% | 0.33% |
| Patients with More than one race3 | 2.46% | 1.33% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 26.23% | 31.23% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 3.03% | 1.66% |
| Unreported/Refused to Report Race and Ethnicity | 10.81% | 13.95% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 2,203 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 88.90% |
| COVID-19 Immunization Series Completed | 3,493 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 86.47% |
| COVID-19 Immunization Series Additional | 59 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 52.94% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 9.03% | 11.34% | 40.68% |
| White, Hispanic/Latino Patients | 14.57% | 16.63% | 8.47% |
| Black/African American, Non-Hispanic/Latino Patients | 19.84% | 18.67% | 16.95% |
| Black/African American, Hispanic/Latino Patients | 3.27% | 2.46% | 3.39% |
| Asian Patients3 | 0.77% | 1.66% | 3.39% |
| American Indian/Alaska Native Patients3 | 0.45% | 0.37% | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.68% | 0.40% | 1.69% |
| Patients with More than one race3 | 1.82% | 1.77% | 0.00% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 30.91% | 30.49% | 11.86% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 8.08% | 6.78% | 5.08% |
| Unreported/Refused to Report Race and Ethnicity | 10.58% | 9.42% | 8.47% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 0.00% |
| 1 to 24 Hours | 33.33% |
| More Than 24 Hours | 58.33% |
| N/A | 8.33% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 16.67% |
| Staffing to administer the vaccine | 25.00% |
| Vaccine confidence | 41.67% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 16.67% |
| Other | 0.00% |
| None | 33.33% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 105.83% |
| Average Percent of Health Center Visits Conducted Virtually | 32.50% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 58.33% |
| Number of Mobile Van Sites | 12 |
| Number of Pop-up Clinics | 99 |
| Number of School-Based Vaccination Sites | 18 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 0.00% |
| Refer patients to another organization that provides monoclonal antibody therapies | 75.00% |
| None | 25.00% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 0.00% |
| Patient awareness/education | 0.00% |
| Staffing capacity | 0.00% |
| Therapy administration/onsite logistics | 8.33% |
| Other | 16.67% |
| None | 75.00% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
